The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location

The aim of the study was the evaluation whether in primary colorectal cancer (CRC) patients (<i>n</i> = 55): age, sex, TNM classification results, WHO grade, tumor location (proximal colon, distal colon, rectum), tumor size, platelet count (PLT), mean platelet volume (MPV), mean platelet...

Full description

Bibliographic Details
Main Authors: Olga Martyna Koper-Lenkiewicz, Violetta Dymicka-Piekarska, Anna Justyna Milewska, Justyna Zińczuk, Joanna Kamińska
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/8/1382
_version_ 1797524153378537472
author Olga Martyna Koper-Lenkiewicz
Violetta Dymicka-Piekarska
Anna Justyna Milewska
Justyna Zińczuk
Joanna Kamińska
author_facet Olga Martyna Koper-Lenkiewicz
Violetta Dymicka-Piekarska
Anna Justyna Milewska
Justyna Zińczuk
Joanna Kamińska
author_sort Olga Martyna Koper-Lenkiewicz
collection DOAJ
description The aim of the study was the evaluation whether in primary colorectal cancer (CRC) patients (<i>n</i> = 55): age, sex, TNM classification results, WHO grade, tumor location (proximal colon, distal colon, rectum), tumor size, platelet count (PLT), mean platelet volume (MPV), mean platelet component (MCP), levels of carcinoembryonic antigen (CEA), cancer antigen (CA 19-9), as well as soluble lectin adhesion molecules (L-, E-, and P-selectins) may influence circulating inflammatory biomarkers: IL-6, CRP, and sCD40L. We found that CRP concentration evaluation in routine clinical practice may have an advantage as a prognostic biomarker in CRC patients, as this protein the most comprehensively reflects clinicopathological features of the tumor. Univariate linear regression analysis revealed that in CRC patients: (1) with an increase in PLT by 10 × 10<sup>3</sup>/μL, the mean concentration of CRP increases by 3.4%; (2) with an increase in CA 19-9 of 1 U/mL, the mean concentration of CRP increases by 0.7%; (3) with the WHO 2 grade, the mean CRP concentration increases 3.631 times relative to the WHO 1 grade group; (4) with the WHO 3 grade, the mean CRP concentration increases by 4.916 times relative to the WHO 1 grade group; (5) with metastases (T1-4N+M+) the mean CRP concentration increases 4.183 times compared to non-metastatic patients (T1-4N0M0); (6) with a tumor located in the proximal colon, the mean concentration of CRP increases 2.175 times compared to a tumor located in the distal colon; (7) in patients with tumor size > 3 cm, the CRP concentration is about 2 times higher than in patients with tumor size ≤ 3 cm. In the multivariate linear regression model, the variables that influence the mean CRP value in CRC patients included: WHO grade and tumor localization. R<sup>2</sup> for the created model equals 0.50, which indicates that this model explains 50% of the variance in the dependent variable. In CRC subjects: (1) with the WHO 2 grade, the mean CRP concentration rises 3.924 times relative to the WHO 1 grade; (2) with the WHO 3 grade, the mean CRP concentration increases 4.721 times in relation to the WHO 1 grade; (3) with a tumor located in the rectum, the mean CRP concentration rises 2.139 times compared to a tumor located in the distal colon; (4) with a tumor located in the proximal colon, the mean concentration of CRP increases 1.998 times compared to the tumor located in the distal colon; if other model parameters are fixed.
first_indexed 2024-03-10T08:53:20Z
format Article
id doaj.art-29e149e08cee4e968a2536b9ec496dda
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T08:53:20Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-29e149e08cee4e968a2536b9ec496dda2023-11-22T07:19:42ZengMDPI AGDiagnostics2075-44182021-07-01118138210.3390/diagnostics11081382The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and LocationOlga Martyna Koper-Lenkiewicz0Violetta Dymicka-Piekarska1Anna Justyna Milewska2Justyna Zińczuk3Joanna Kamińska4Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Białystok, PolandDepartment of Clinical Laboratory Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Białystok, PolandDepartment of Statistics and Medical Informatics, Medical University of Bialystok, Szpitalna 37, 15-295 Białystok, PolandDepartment of Clinical Laboratory Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Białystok, PolandDepartment of Clinical Laboratory Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Białystok, PolandThe aim of the study was the evaluation whether in primary colorectal cancer (CRC) patients (<i>n</i> = 55): age, sex, TNM classification results, WHO grade, tumor location (proximal colon, distal colon, rectum), tumor size, platelet count (PLT), mean platelet volume (MPV), mean platelet component (MCP), levels of carcinoembryonic antigen (CEA), cancer antigen (CA 19-9), as well as soluble lectin adhesion molecules (L-, E-, and P-selectins) may influence circulating inflammatory biomarkers: IL-6, CRP, and sCD40L. We found that CRP concentration evaluation in routine clinical practice may have an advantage as a prognostic biomarker in CRC patients, as this protein the most comprehensively reflects clinicopathological features of the tumor. Univariate linear regression analysis revealed that in CRC patients: (1) with an increase in PLT by 10 × 10<sup>3</sup>/μL, the mean concentration of CRP increases by 3.4%; (2) with an increase in CA 19-9 of 1 U/mL, the mean concentration of CRP increases by 0.7%; (3) with the WHO 2 grade, the mean CRP concentration increases 3.631 times relative to the WHO 1 grade group; (4) with the WHO 3 grade, the mean CRP concentration increases by 4.916 times relative to the WHO 1 grade group; (5) with metastases (T1-4N+M+) the mean CRP concentration increases 4.183 times compared to non-metastatic patients (T1-4N0M0); (6) with a tumor located in the proximal colon, the mean concentration of CRP increases 2.175 times compared to a tumor located in the distal colon; (7) in patients with tumor size > 3 cm, the CRP concentration is about 2 times higher than in patients with tumor size ≤ 3 cm. In the multivariate linear regression model, the variables that influence the mean CRP value in CRC patients included: WHO grade and tumor localization. R<sup>2</sup> for the created model equals 0.50, which indicates that this model explains 50% of the variance in the dependent variable. In CRC subjects: (1) with the WHO 2 grade, the mean CRP concentration rises 3.924 times relative to the WHO 1 grade; (2) with the WHO 3 grade, the mean CRP concentration increases 4.721 times in relation to the WHO 1 grade; (3) with a tumor located in the rectum, the mean CRP concentration rises 2.139 times compared to a tumor located in the distal colon; (4) with a tumor located in the proximal colon, the mean concentration of CRP increases 1.998 times compared to the tumor located in the distal colon; if other model parameters are fixed.https://www.mdpi.com/2075-4418/11/8/1382colorectal cancerbiomarkerinflammationlinear regression analysisprognostic value
spellingShingle Olga Martyna Koper-Lenkiewicz
Violetta Dymicka-Piekarska
Anna Justyna Milewska
Justyna Zińczuk
Joanna Kamińska
The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location
Diagnostics
colorectal cancer
biomarker
inflammation
linear regression analysis
prognostic value
title The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location
title_full The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location
title_fullStr The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location
title_full_unstemmed The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location
title_short The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location
title_sort relationship between inflammation markers crp il 6 scd40l and colorectal cancer stage grade size and location
topic colorectal cancer
biomarker
inflammation
linear regression analysis
prognostic value
url https://www.mdpi.com/2075-4418/11/8/1382
work_keys_str_mv AT olgamartynakoperlenkiewicz therelationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation
AT violettadymickapiekarska therelationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation
AT annajustynamilewska therelationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation
AT justynazinczuk therelationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation
AT joannakaminska therelationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation
AT olgamartynakoperlenkiewicz relationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation
AT violettadymickapiekarska relationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation
AT annajustynamilewska relationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation
AT justynazinczuk relationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation
AT joannakaminska relationshipbetweeninflammationmarkerscrpil6scd40landcolorectalcancerstagegradesizeandlocation